Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
May 31st, 2008
In response to ever increasing cardiac toxicity found in market drugs, Gwathmey Preclinical Testing Services, Inc. announced the launch of new Cardionomics(TM) services and the formation of its Cardionomics(TM) Advisory Board to provide new methods and technologies to improve cardiac safety of drug candidates. Cardiac toxicity has played a major role in shutting down the sales of major drugs over the past 30 years. It is estimated that 28 percent of major drugs had to be withdrawn in that period due to cardiac side effects. When major drugs have to be withdrawn, the financial and safety consequences for the global pharmaceutical industry can be huge in terms of patient...
Source: Law & Health Weekly (2008-05-31)
|
